Organon holds special shareholder meeting on merger agreement proposal

Organon held a special shareholder meeting on July 23, 2026 to vote on a merger agreement with Sun Pharmaceutical Holdings USA.

Shareholders adopted the merger agreement, authorizing the transaction to proceed subject to completion of the merger.

Investors also backed a non-binding advisory resolution on merger-related executive compensation.